IMMULITE Systems Free PSA
Siemens Medical Solutions Diagnostics Limited · Decision date Sep 22, 2026
What did the FDA decide?
The FDA recorded a 30-Day Notice decision, OK30, dated 2026-09-22 for P060005/S027, a supplement to the IMMULITE Systems Free PSA application held by Siemens Medical Solutions Diagnostics Limited. The supplement type is a 30-Day Notice and the recorded reason is a process change affecting a manufacturer, sterilizer, packager or supplier. The stated scope is to move manufacturing of a critical component within the same facility.
The underlying device category is a free prostate specific antigen (noncomplexed) test intended to distinguish prostate cancer from benign conditions, classified under Immunology with product code MTG. This record covers only the manufacturing-location change described; it is not a new approval of the whole system, and the source does not identify the component, the facility, or any performance data. Whether the change affects analytical performance or labeling remains unknown from this record.
FDA approval order statement
to move manufacturing of a critical component within the same facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Immunology
- Decision date
- Sep 22, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060005/S027
- Regulatory pathway
- PMA supplement
- Product code
- MTG
- Decision code
- OK30
- Decision date
- Sep 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions.
- Product code
- MTG
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060005. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060005 · Original PMA
IMMULITE / IMMULITE 1000 AND IMMULITE 2000 FREE PSA ASSAYS
P060005/S027 received
Application receipt date recorded by FDA.
P060005/S027 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P060005. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060005
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Siemens Medical Solutions Diagnostics Limited | PMA approval | May 11, 2007 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Siemens Medical Solutions Diagnostics Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Glyn Rhonwy Llanberis, Caernarfon, Gwynedd Ll55, 4EL
Sources and methodology
- Original FDA record: P060005/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records